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Aberrantly short telomeres result in decreased
longevity in both humans and mice with defective
telomere maintenance. Normal populations of hu-
mans and mice present high interindividual variation
in telomere length, but it is unknown whether this is
associated with their lifespan potential. To address
this issue, we performed a longitudinal telomere
length study along the lifespan ofwild-type and trans-
genic telomerase reverse transcriptase mice. We
found that mouse telomeres shorten 100 times
faster than human telomeres. Importantly, the rate of
increase in the percentage of short telomeres, rather
than the rate of telomere shortening per month, was
a significant predictor of lifespan in both mouse
cohorts, and those individuals who showed a higher
rate of increase in the percentage of short telomeres
were also the oneswith a shorter lifespan. These find-
ings demonstrate that short telomeres have a direct
impact on longevity in mammals, and they highlight
the importance of performing longitudinal telomere
studies to predict longevity.
INTRODUCTION
Telomeres are repeated DNA nucleoprotein structures at the
ends of eukaryotic chromosomes (Blackburn, 1991; de Lange,
2005) that protect them from degradation and DNA repair activ-
ities, and are essential for chromosomal stability (Chan and
Blackburn, 2002). Telomere repeats can be added de novo by
telomerase, a reverse transcriptase that elongates telomeres in
cells in which it is expressed (Blackburn, 2005; Flores et al.,
2006; Greider, 1998; Greider and Blackburn, 1985; Marion
et al., 2009). In telomerase-negative cells, telomeres shorten
with each round of cell division as a result of end replication
and DNA-degrading activities. Short telomeres are passed
onto daughter cells, and thus telomere shortening is exacer-
bated by cell division and increasing age in both humans and
mice (Flores et al., 2008; Harley et al., 1990). Critically short telo-
meres can trigger a persistent DNA damage response that leads
to cellular senescence and/or apoptosis (Collado et al., 2007;732 Cell Reports 2, 732–737, October 25, 2012 ª2012 The AuthorsDeng et al., 2008), eventually compromising the regenerative
capacity and function of tissues (Blasco, 2007). Short telomeres
are proposed to be sufficient to cause the degenerative pathol-
ogies associated with aging even in the presence of telomerase
activity (Armanios et al., 2009; Hao et al., 2005).
In further support of this notion, both telomerase-deficient
mice and human diseases due to mutations in telomerase
components result in accelerated-aging phenotypes and
decreased longevity due to premature depletion of stem cells
and subsequent organ/tissue failure (Armanios et al., 2007;
Blasco et al., 1997; Garcı´a-Cao et al., 2006; Herrera et al.,
1999; Mitchell et al., 1999; Tsakiri et al., 2007; Vulliamy et al.,
2001; Yamaguchi et al., 2005). Telomere shortening associated
with normal aging can be influenced by known risk factors for
disease and premature death, such as psychological stress,
smoking, cognitive impairment, and obesity (Canela et al.,
2007; Cawthon et al., 2003; Cherkas et al., 2006; Epel et al.,
2004; Valdes et al., 2005). However, whether the rate of telomere
shortening in individual mammals has an influence on their
longevity remains unexplored. In this regard, although serial telo-
mere length measurements were previously obtained in
baboons, a correlationwith longevity was not sought (Baerlocher
et al., 2003). Of interest, it was recently reported that telomere
length measured at 25 days of age is a predictor of lifespan in
birds (Heidinger et al., 2012).
Evidence from telomerase loss-of-expression and gain-of-
expression transgenic mouse models suggests that telomere
length may be rate limiting for mouse longevity (Garcı´a-Cao
et al., 2006; Toma´s-Lobaet al., 2008).Nonetheless, a role for telo-
mere length in normalmouseaging is brought intoquestionby the
fact that although mice have very long telomeres compared with
humans (50 kb in young C57BL/6 mice, compared with15 kb
in young humans) (Gomes et al., 2011; Wright and Shay, 2000),
mice have a much shorter maximal lifespan (5 years in mice of
mixed background homozygous [/] for the GHR/BP gene)
(Brown-Borg and Bartke, 2012) than humans (122 years).
Although numerous studies have measured the average rate of
telomere shortening per year in human population studies, which
ranges from 31 base pairs (bp)/year to 72 bp/year in peripheral
blood cells (Canela et al., 2007; Hastie et al., 1990; Slagboom
et al., 1994; Vaziri et al., 1993), this rate has not been obtained
in mice. Moreover, only one study has linked the increase in the
percentage of short telomeres with age in humans, which was
calculated as a 0.6% increase per year (Canela et al., 2007).
Figure 1. Mouse Telomeres Shorten 100-
Fold Faster than Human Telomeres with
Aging
(A) Kaplan-Meyer survival curves of the indicated
cohorts. Arrows indicate time of blood extraction.
(B and C) The mean telomere length (B) and per-
centage of short telomeres (C) were determined
by HT-QFISH on white blood cells (n, number
of mice). Values are given as average ± SEM, and
statistical significance was determined by one-
tailed Student’s t test. (B) From left to right
(average ± SEM): 51.49 ± 1.633, 45.10 ± 1.322,
43.18 ± 1.118, 37.51 ± 2.241, 52.61 ± 2.049,
46.06 ± 2.142, 40.54 ± 2.053, 38.55 ± 1.801. (C)
From left to right (average ± SEM): 12.78 ± 0.8693,
16.19 ± 0.8230, 17.99 ± 1.257, 25.14 ± 3.552,
12.16 ± 1.078, 16.68 ± 1.237, 20.77 ± 1.798,
21.93 ± 2.581.
(D and E) Adjustment of mean telomere length (D)
and percentage of short telomeres (E) with aging
to a linear or quadratic model. Second-order
polynomial adjustment (quadratic) was used for
the nonlinear fit model.Here, we reasoned that the rate of increase in the percentage
of short telomeres and the rate of telomere shortening
throughout the lifespan of individuals might explain the different
longevities of wild-type (WT) mice and humans, as well as the
interindividual variations in longevity in mammals.
RESULTS AND DISCUSSION
With the aim of determining the rate of telomere shortening and
the rate of increase in the percentage of short telomeres with
aging in mice, we performed longitudinal telomere length deter-
minations in the blood of individual mice by using an automated
high-throughput quantitative fluorescence in situ hybridization
(HT-QFISH) platform (Canela et al., 2007).
To correct for gender and genetic background, as well as to
circumvent possible effects of reproduction on telomere length,
we used only male mice of a 100% C57BL/6 background.
In addition, the mice were individually housed at 3 months ofCell Reports 2, 732–737,age and fed a defined diet of 92.5 kcal
per week (see Experimental Procedures).
This caloric intake represents 10%
fewer calories than the average daily
intake of C57BL/6 mice, and was used
to avoid a possible impact of obesity on
longevity. In parallel, we determined
the same parameters in a transgenic
mouse line overexpressing the mouse
catalytic subunit of telomerase reverse
transcriptase (TERT) in various epithelial
tissues (hereafter termed transgenic
TERT [TgTERT]; Gonza´lez-Sua´rez et al.,
2001, 2002). This mouse line has a
comparable 100%C57BL/6 background;
however, it presents delayed signs of
aging compared with WT mice (Gonza´-lez-Sua´rez et al., 2005; this work), as well as a 40% increase in
median longevity when combined with overexpression of tumor
suppressor genes (Toma´s-Loba et al., 2008). As shown in Fig-
ure 1A, the TgTERT mice used here show a delayed onset of
the first deaths in the colony compared with the WT cohorts
(see Figure 1A), in agreement with their increased healthspan.
Thus, we set out to study whether any telomere-related param-
eter could predict longevity in these two independent mouse
cohorts (TgTERT and WT) with slightly different longevities.
For cell analyses, we used peripheral blood leukocytes (PBLs),
which are widely used for human telomere length studies
because hematopoietic stems cells proliferate throughout life
and thus reflect on cellular turnover associated with the aging
process. Telomere length measurements in the blood have
been shown to be representative of the general health status in
humans (Canela et al., 2007; Cawthon et al., 2003; Collerton
et al., 2007; Mainous et al., 2010; Valdes et al., 2005) and mice
(Bernardes de Jesus et al., 2012), and provide an indicator ofOctober 25, 2012 ª2012 The Authors 733
the general healthspan. In this regard, although the TERT trans-
genic mice used here do not target telomerase to blood cells,
TERT expression in these mice has systemic beneficial effects
that delay aging (Toma´s-Loba et al., 2008), as also observed
recently when a gene therapy strategy was used to overexpress
TERT late in life (Bernardes de Jesus et al., 2012). We extracted
300 ml of blood from the facial vein of each mouse at 4, 8, 12,
and 25 months of age (see Experimental Procedures) and the
mice were left to age until the end of their lifespan, to obtain
their complete longevity curve (Figure 1A). To avoid morbidity
associated with this procedure in old mice, blood extractions
were not performed after 25 months of age. Of note, we
observed a delay in the age at onset of first death in the
TgTERT cohort: the first mouse died at >100 weeks of age,
compared with <50 weeks of age in the case of the WT cohort
(Figure 1A). We determined both the average telomere length
and the percentage of short telomeres at the indicated time
points per individual mouse by using HT-QFISH (Canela et al.,
2007). HT-QFISH is able to measure individual telomere signals
at a single-cell level in interphasic nuclei. In this setting, each
telomere signal corresponds to a clustering of few individual
telomeres. The percentage used to represent short telomeres
by HT-QFISH usually corresponds to the 10%–20% percentile
in the reference population (in this case, we used 4-month-
old WT mice as reference), which is 15 kb. We previously deter-
mined that telomere signals <15 kb are a good indicator of the
presence of short telomeres in mouse blood cells and reflect
differences in telomere length between different cohorts and
treatments (Bernardes de Jesus et al., 2012). Therefore, here
we set a cutoff of 15 kb to quantify the presence of short telo-
meres. In addition, we performed correlations with other cutoffs
(<2, <5, and <10 kb), but we observed the strongest correla-
tions at the 15 kb cutoff (not shown).
First, it is apparent that even thoughmouse telomeres are very
long at young ages (>50 kb at 4months of age), they shorten with
age, as reflected by both a significant decrease in the mean telo-
mere length and a significant increase in the percentage of short
telomeres, detectable at 4 month intervals (Figures 1B and 1C).
By adjusting the data to a linear regression model, we deter-
mined a rate of telomere shortening (as estimated by the slope
of the regression line) of 7,000 bp per year (Figure 1D), which
was comparable in both mouse cohorts and is 100 times faster
than that obtained for human PBLs using the same technology
(Canela et al., 2007). These results indicate that even though
mouse telomeres are much longer than human telomeres at
younger ages, they exhibit a much faster rate of shortening
with age, highlighting the relevance of performing longitudinal
telomere length studies rather than measuring telomeres at
a single time point. The rate of increase in the percentage of short
telomeres per year was 6.6% in WT mice and 4.9% in the
TgTERT cohort (as estimated by the slope of the regression
line; Figure 1E).
Next, we investigated whether the telomere length or the
percentage of short telomeres at any of the studied timepoints
is predictive of mouse longevity, as was recently reported for
zebra finches (Heidinger et al., 2012). In the case of mice,
however, we did not find a significant correlation between either
the average telomere length or the percentage of short telomeres734 Cell Reports 2, 732–737, October 25, 2012 ª2012 The Authorswith longevity in anyof the twomouse cohorts,with the exception
of an inverse correlation between average telomere length and
longevity at 12 months of age in the TgTERT mice (Figure S1).
Longitudinal studies allow one to examine telomere dynamics
in a given individual over time. A given rate of telomere short-
ening or a rate of increase in the percentage of short telomeres
is the result of a longitudinal trend in individual mice that may
reflect very complex genetic traits associated with longevity,
which cannot be inferred from a single time-point measurement.
Therefore, we determined the rate of increase in the percentage
of short telomeres per month and the rate of telomere shortening
per month for every mouse under study. Strikingly, we found
a significant correlation between the rate of increase in the
percentage of short telomeres per month and longevity (Fig-
ure 2A), which could be observed in both mouse cohorts, and
between the rate of telomere shortening permonth and longevity
(Figure 2B), which was only observed in WT mice. We also
observed a significant correlation between the rates of increase
in the percentage of short telomeres and mean telomere short-
ening (Figure 2C). Together, these results indicate that the rate
of increase in the percentage of short telomeres is a reliable
and robust predictor of mouse longevity in two different mouse
strains with different TERT expression levels and different
longevities. The mice with the higher rates of increase in the
percentage of short telomeres were the ones that had shorter
lives, while those with lower rates of increase in the percentage
of short telomeres were the ones that enjoyed longer lives.
The fact that the TgTERT cohorts did not show a correlation
between the rate of telomere shortening permonth and longevity
prompted us to address whether this was the consequence of
TgTERT mice showing a delayed time of onset of the first death
in the colony. In particular, to assess whether lifespan can influ-
ence the rate of telomere shortening or the rate of increase in the
percentage of short telomeres, we plotted these two parameters
at different time intervals of measurement (Figure S2). Indeed,
age influenced the rate of mean telomere shortening per month
in a discontinuous manner, so that we found higher rates of telo-
mere shortening per month in young mice compared with older
mice (Figure S2B). Of interest, this was not the case for the
rate of increase in the percentage of short telomeres per month,
which was quite constant at different age intervals in bothmouse
cohorts, with the exception of lower rates of increase in the
percentage of short telomeres in old TgTERT mice (Figure S2A).
The fact that the rate of telomere shortening per month was not
constant with age in both mouse cohorts could account for the
significant correlation between the rate of mean telomere short-
ening per month and longevity in the WT mice but not in the
TgTERT mice (Figure 2B), because a significant fraction of WT
mice (versus only one TgTERTmouse) died beforemeasurement
of the four time points. Indeed, even if we exclude the single
TgTERT mouse that died before the fourth measurement, we
observe a strong correlation between the rate of increase in
the percentage of short telomeres and longevity (Figure S3).
These findings indicate that the rate of increase in the
percentage of short telomeres is a robust and reliable telomere
marker for longevity studies.
It is of interest to note that differences in telomere length and
longevity could not be attributed to differences in gender,
Figure 2. The Rate of Increase in the Per-
centage of Short Telomeres and the Rate
of Telomere Shortening Predicts Mouse
Longevity
(A–C) The percentage of short telomeres (<15 kb; A
and C) and mean telomere length (B and C) were
determined by HT-QFISH on white blood cells (see
Figure 1). Linear regression lineswere calculated for
the values obtained for the rate of increase in the
percentage of short telomeres and for the rate of
mean telomere length shortening (kb/month) versus
lifespan (weeks). (A) Rate of increase in the per-
centage of short telomeres (<15 kb) per month
versus lifespan (weeks). (B) Rate of mean telomere
length shortening (kb/month) versus the rate of
increase in the percentage of short telomeres (per
month). (C)Rateofmean telomere lengthshortening
(kb/month) versus the rate of increase in the
percentage of short telomeres (<15 kb) per month.
The slope of each regression line is indicated.
See also Figures S1, S2, S3, S4, and S5.reproduction, genetic background, or environmental factors, as
only male mice of the C57BL/6 genetic background housed at
our specific pathogen-free (SPF) facility were studied. In this re-
gard, we did not find a correlation between the rate of increase in
the percentage of short telomeres or rates of telomere short-
ening and weight gain with age (Figure S4), which together
with the fact that the mice were fed a defined diet rules out
a possible dietary contribution. These results suggest that differ-
ences in the rate of increase in the percentage of short telomeres
or in the rate of telomere shortening, which have been shown to
vary among individuals of the same age in different species (Can-
ela et al., 2007; Heidinger et al., 2012; Monaghan, 2010), may be
the result of small differences inmodifier genes, or environmental
factors, and offer an experimental platform to uncover new
factors for modulation of aging and longevity.
Finally, we sought to determinewhether variations in the rate of
increase in the percentage of short telomeres had an impact on
pathologies foundat the timeof death. To that end,weperformed
a full histopathological analysis of mice under study at their
endpoint. The more prevalent pathologies found in C57BL/6
mice at their time of death are cancer (in 50%–80% of mice)
and age-associated pathologies (50%–20%) (Gonza´lez-
Sua´rez et al., 2002; Herranz et al., 2010; Toma´s-Loba et al.,
2008). We first determined whether the incidence of malignant
cancers (lymphoma, sarcoma, and adenocarcinoma) showed
any differential prevalence in mice belonging to either the higher
or lower quartile of rate of increase in thepercentage of short telo-
meres. We found a similar incidence of cancer or degenerativeCell Reports 2, 732–737,diseases in both cases, in spite of the
fact that mice belonging to the higher
quartile of rate of increase in the percent-
age of short telomeres showed a median
age at death of 105 weeks, compared
with 140 weeks in the case of mice
belonging to the lower quartile (FigureS5).
We observed the same tendency in the
TgTERT cohort, and mice belonging tothe higher quartile of rate of increase in the percentage of short
telomeres showed a median age at death of 116 weeks,
compared with 149 weeks in the case of mice belonging to the
lower quartile.
Collectively, these findings demonstrate that the rate of
increase in the percentage of short telomeres during an individ-
ual’s lifetime, rather than the rate of telomere shortening over
time, determines longevity inmice. These results bring into ques-
tion the prevailing viewpoint that telomere shortening does not
influence replicative aging in WT mice (Gomes et al., 2011;
Wright and Shay, 2000), and highlight the importance of perform-




Male mice of a 100% C57BL/6 background were produced and stored at the
SPF barrier area of the Spanish National Cancer Center, in accordance with
the recommendations of the Federation of European Laboratory Animal
Science Associations.
In this study we used a total of 38 mice (20 WT and 18 TgTERT; Figure 1B).
Two mice from each cohort were sacrificed after the last telomere length
measurement point for experimentation, and were excluded from the survival
curves and other correlations involving final lifespan.
Experimental Setup
After weaning, five mice were housed per cage and fed a nonpurified diet (No.
2018; Harlan) ad libitum. For the aging study, 3-month-old mice were individ-
ually housed and were fed 92.5 kcal per week of chemically defined controlOctober 25, 2012 ª2012 The Authors 735
diet (AIN-93M, diet No. F05312; Bio-Serv). This caloric intake was10% fewer
calories than the average daily intake of C57BL/6 mice, to ensure that all food
was consumed. Defined diets were cold-packed into 1 g pellets. The mice
were fed two-sevenths of the weekly allotment of food on Monday and
Wednesday, and three-sevenths of that amount of Friday (Dhahbi et al.,
2004; Pugh et al., 1999).
Mice were inspected on a daily basis and sacrificed when they presented
signs of illness or tumors, in accordance with the Guidelines for Humane
Endpoints for Animals Used in Biomedical Research (Harrison et al., 2009).
The date of euthanasia was considered as an estimation of the natural lifespan.
The mice were subjected to necropsy and histopathological analysis.
Histological Analysis
Histopathology was performed as previously described (Gonza´lez-Sua´rez
et al., 2001). Briefly, tissues and organs were fixed for 24 hr in a 10% neutral
buffered formalin solution at room temperature, dehydrated through graded
alcohols and xylene, and embedded in paraffin. Histological analysis was
achieved on 4–5 mm sections according to standard procedures. Cancer-
related pathologies and senile lesions were grouped as described previously
(Toma´s-Loba et al., 2008).
HT-QFISH on PBLs
Blood was extracted from the facial vein at the indicated time points. Upon
erythrocyte lysis (buffer EL; Qiagen), PBLs were plated on a clear-bottom,
black-walled, 96-well plate, and HT-QFISH was performed as previously
described (Canela et al., 2007). The accuracy and sensitivity of HT-QFISH
are similar to those of telomere QFISH on metaphasic chromosomes (Canela
et al., 2007). We analyzed telomere length values using individual telomere
spots (>5,000 per sample) corresponding to the specific binding of a Cy3-
labeled telomeric probe. Fluorescence intensities were converted into kilo-
bases as described previously (Canela et al., 2007; McIlrath et al., 2001).
Statistical Analysis
A log-rank test was used to calculate statistical differences in the survival
curves. Student’s t-test was used to calculate the statistical significance of
the mean telomere and short telomere variation over time. To calculate the
rate of increase in the percentage of short telomeres and the rate of mean telo-
mere shortening, linear regression lines were calculated for each mouse with
GraphPad Prism, representing the best-fit values of the four values calculated
at the different time points (either percentage of short telomeres or mean telo-
mere length). For mice that died before the acquisition of all time points, linear
regression lines were determined from the available measurements. The p
value was calculated by dividing the slope by its standard error, and repre-
sents the correlation between the axes (slope significantly different from
zero). Pathological analysis was calculated with the c2 test.
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